New data fails to quiet cholesterol drug debate
New data about the controversial cholesterol fighter Vytorin failed to quell touching to that the drug might not be as good as thought at keeping heart disease at bay, leading an expert panel to recommend on Sunday that patients stick with statins. More: - Brought to my attention by
More: continued here